EPHX2 and acute kidney injury: The potential for targeting sEH to affect AKI risk was demonstrated in a murine model of IR injury, in which administration of a sEH inhibitor prior to IR attenuated renal functional decline, tubular necrosis, and renal inflammation compared to vehicle, and the severity of IR-induced renal damage correlated inversely with endogenous EET levels [16].